Differences in perinatal and infant mortality in high-income countries: Artifacts of birth registration or evidence of true differences? by Deb-Rinker, Paromita et al.
RESEARCH ARTICLE Open Access
Differences in perinatal and infant mortality
in high-income countries: artifacts of birth
registration or evidence of true differences?
Paromita Deb-Rinker1*, Juan Andrés León1, Nicolas L. Gilbert1, Jocelyn Rouleau1, Anne-Marie Nybo Andersen2,
Ragnheiður I. Bjarnadóttir3, Mika Gissler4, Laust H. Mortensen2, Rolv Skjærven5, Stein Emil Vollset5, Xun Zhang6,
Prakesh S. Shah7, Reg S. Sauve8, Michael S. Kramer6, K. S. Joseph9 and for the Canadian Perinatal Surveillance
System (Public Health Agency of Canada)
Abstract
Background: Variation in birth registration criteria may compromise international comparisons of fetal and infant
mortality. We examined the effect of birth registration practices on fetal and infant mortality rates to determine
whether observed differences in perinatal and infant mortality rates were artifacts of birth registration or reflected
true differences in health status.
Methods: A retrospective population-based cohort study was done using data from Canada, United States,
Denmark, Finland, Iceland, Norway, and Sweden from 1995–2005. Main outcome measures included live births by
gestational age and birth weight; gestational age—and birth weight-specific stillbirth rates; neonatal, post-neonatal,
and cause-specific infant mortality.
Results: Proportion of live births <22 weeks varied substantially: Sweden (not reported), Iceland (0.00 %), Finland
(0.001 %), Denmark (0.01 %), Norway (0.02 %), Canada (0.07 %) and United States (0.08 %). At 22–23 weeks, neonatal
mortality rates were highest in Canada (892.2 per 1000 live births), Denmark (879.3) and Iceland (1000.0), moderately
high in the United States (724.1), Finland (794.3) and Norway (739.0) and low in Sweden (561.2). Stillbirth:live birth
ratios at 22–23 weeks were significantly lower in the United States (79.2 stillbirths per 100 live births) and Finland
(90.8) than in Canada (112.1), Iceland (176.2) and Norway (173.9). Crude neonatal mortality rates were 83 % higher
in Canada and 96 % higher in the United States than Finland. Neonatal mortality rates among live births ≥28 weeks
were lower in Canada and United States compared with Finland. Post-neonatal mortality rates were higher in
Canada and United States than in Nordic countries.
Conclusions: Live birth frequencies and stillbirth and neonatal mortality patterns at the borderline of viability are
likely due to differences in birth registration practices, although true differences in maternal, fetal and infant health
cannot be ruled out. This study emphasises the need for further standardisations, in order to enhance the relevance
of international comparisons of infant mortality.
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Background
The infant mortality rate is a key population health indica-
tor and commands widespread public attention since it re-
flects economic development, social equity, and health care
services within a population [1]. It’s ready availability and
importance as a health indicator makes the infant mortality
rate a common tool for international comparisons of health
status [2]. Several institutions like the United Nations
Children’s Fund (UNICEF) and the Organization for
Economic Cooperation and Development (OECD) use this
and related indicators to rank countries annually [3, 4].
The popularity of the infant mortality indicator notwith-
standing, international variations in birth registration laws
and practices have the potential to bias comparisons of in-
fant mortality. Problems can arise from differential registra-
tion of live births and stillbirths, especially births occurring
at the borderline of viability (e.g., gestational age <22 weeks
or a birth weight <500 grams, who typically do not survive
the neonatal period), and/or their classification as stillbirths
versus live births [5]. It is important to ascertain if inter-
national rankings by perinatal or infant mortality are af-
fected by the above-mentioned biases, as such rankings
often serve as the basis for evaluating national health care
systems and for changing health policy. Although several
studies [6–8] have suggested that variations in birth
registration challenge international comparisons among
high-income countries, the practice of annually ranking
and comparing international infant mortality rates re-
mains in vogue.
We examined variations in infant and fetal mortality
rates based on birth registration practices at the border-
line of viability, and the potentially differential classifica-
tion of stillbirths and live births. We compared Canada
and the United States to the Nordic countries because of
the reported low levels of perinatal and infant mortality
in the Nordic countries and their widely known em-
phasis on egalitarian ideals [9], lesser social disparities
[10], and high quality of perinatal care [11].
Methods
We used data for the period 1995 to 2005 from
Canada, the United States and all five Nordic countries
(Denmark, Finland, Iceland, Norway, and Sweden). We
obtained reported counts of live births, stillbirths, neo-
natal deaths (0–27 days after birth) and post-neonatal
deaths (28–364 days) by gestational age (GA) and birth
weight (BW) from the vital registration systems or
birth registries of each country. The gestational age cat-
egories that we examined included <22, 22–23, 24–25, 26–
27, 28–31, 32–36, 37–41, ≥42 weeks and unknown gesta-
tional age, and birth weight categories included <500, 500–
749, 750–999, 1000–1499, 1500–1999, ≥2000 grams and
unknown birth weight. We also obtained reported counts
of neonatal, post-neonatal, and infant deaths by cause of
death (congenital anomalies, immaturity-related and other
causes). In addition, we collected and contrasted the rules
and registration requirements for stillbirths and live births
for each country.
We obtained birth cohort linked live birth-infant death
and fetal death data files for Canada from the vital regis-
tration files of Statistics Canada through an agreement
between the Public Health Agency of Canada and Statistics
Canada (which grants permission to the Agency to use this
data). We excluded data from Ontario because of data
quality concerns [12]. We obtained information from
the United States from the birth cohort linked live
birth-infant death data files and fetal death data files
from the National Center for Health Statistics. Foreign
residents and infants born at <20 weeks’ gestation in
the United States were excluded from the study. We
obtained Danish data from the Cause of Death Register
and the Medical Birth Register of Denmark. The analyses
were approved by the Danish Data Protection Agency. We
obtained data for Finland from the Medical Birth Register
of the National Institute for Health and Welfare (THL)
and Cause-of-Death Register of Statistics Finland (no ap-
proval was needed). We obtained data for Iceland from
the Landspitali University Hospital and participation in
the study was approved by the Icelandic Directorate of
Health. We obtained data for Norway from the Medical
Birth Registry of Norway (MBRN) and the Cause of Death
Registry. The data delivery was authorized by Medisinsk
fødselsregisterforskriften. Data from Sweden was based on
information from the Medical Birth Register and the Cause
of Death Register and restricted to live births >22 weeks
and stillbirths >28 weeks. Analyses of individual data were
performed at Karolinska Institutet and permission was
granted by the Ethical Committee of Karolinska Institutet.
Gestational age in Canada was based on the best clinical
estimate of pregnancy duration as reported on the birth
registration [12], while in the United States it was based on
the last menstrual period substituted by the best clinical es-
timate of gestation (where available) if different from the
menstrual estimate [13–15]. In Denmark, gestational age
represented the clinical estimate made by the midwife at
birth based on a combination of menstrual dates, menstrual
cycle information and ultrasound scans (with approxi-
mately 70 % of women having received an ultrasound scan
at 18 weeks gestation). In Sweden, gestational age was
based on a hierarchical assessment, with 95 % of values
based on early second trimester ultrasound and the remain-
der on menstrual dating or a pediatric assessment of the in-
fant at birth [16]. Gestational age estimates in Finland,
Iceland, and Norway were also based on a combination of
information from menstrual, ultrasound and clinical dating.
We calculated the reported proportion of live births at
each gestational age and birth weight category, and neo-
natal mortality rates by gestational age and birth weight.
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Similar analyses were carried out for stillbirth and post-
neonatal mortality rates. Gestational age—and birth weight-
specific stillbirth:live birth ratios (stillbirths per 100 live
births) were also calculated to assess any proclivity towards
labeling live births as stillbirths near the threshold of viabil-
ity. Other comparisons included contrasts of cause of infant
death, perinatal mortality and feto-infant mortality.
For all contrasts of interest, we calculated mortality rate
ratios and 95 % confidence intervals to determine the mag-
nitude and statistical significance of observed differences.
We used Finland as the reference group for these calcula-
tions, as it had a reasonably large number of live births and
mortality rates that were not outliers relative to other Nor-
dic countries. We assessed the statistical significance of dif-
ferences in rate ratios using 95 % confidence intervals and
based on a test of heterogeneity of the odds ratios [17].The
manuscript was prepared in line with the STROBE guide-
lines (see Additional file 1: STROBE Checklist).
Results
Gestational age and birth weight criteria for the registration
of live births and stillbirths differed internationally. Coun-
tries such as Canada, the United States, Denmark, Finland,
Iceland and Sweden required live birth registration for “any
product of conception that shows signs of life at birth,”
while Norway required registration of live births at a gesta-
tional age ≥16 weeks. Canada, Finland and Iceland required
registration for stillbirths with a gestational age at delivery
of ≥20 weeks or a birth weight ≥500 g; these criteria were
≥20 weeks or ≥350 g in the United States. The stillbirth
registration criterion for fetal deaths was ≥16 weeks in
Norway and ≥28 weeks in Sweden (until 2008), while
Denmark changed its criterion from ≥28 weeks to
≥22 weeks in 2004. Canada, Denmark, Iceland and Sweden
required stillbirth registration following medical pregnancy
termination if birth weight and gestational age criteria for
stillbirth were satisfied, whereas the United States, Finland
and Norway required reporting of such cases as pregnancy
terminations but not as stillbirths (Table 1).
The proportions of live births <22 and 22–23 weeks were
significantly higher in Canada and (especially) the United
States as compared with the Nordic countries (Table 2).
Differences between Canada and the Nordic countries were
less evident at 24–25, 26–27 and 28–31 weeks gestation
(with rates at 28–31 weeks being higher in Denmark and
Norway than in Canada), although rates in the United
States remained higher than in the other countries. Sub-
stantially higher proportions of live births with birth
weights <500 g were reported in Canada and especially the
United States compared with the Nordic countries. How-
ever, this pattern of variation was not observed among live
births 750–999 g, 1000–1499 g and 1500–1999 g, with
Canada (but not the United States) having rates similar to
the Nordic countries (Table 2). The Nordic countries had
higher rates of post-term births (≥42 weeks) compared with
Canada and the United States.
At 22–23 weeks gestation, Iceland had the highest neo-
natal mortality rate (1000.0 per 1000 live births); similar
rates were observed in Canada and Denmark. Rates in
Finland (794.3 per 1000 live births) were lower and similar
to rates in the United States and Norway, while Sweden’s
rates were significantly lower than in any other country
(561.2 per 1000 live births, 95 % CI 506.2 to 615.1,
P < 0.05). The mortality rate patterns were similar at 24–25
weeks between countries, but differed at later gestational
ages. At 37–41 weeks gestation, neonatal mortality rates
were lowest in Iceland, highest in Denmark and not signifi-
cantly different among the other countries (Table 3). Pat-
terns of birth weight-specific neonatal mortality were
similar to those based on gestational age. Ratios of still-
births to live births varied widely, with ratios in Canada
lower than those in the United States, Finland and Norway
Table 1 Gestational age and birth weight criteria for registration of live births and stillbirths among selected high-income countries,
1995–2005
Country Live birth Stillbirth Stillbirth registration
following termination
of pregnancya
Canada Any signs of life regardless of gestational age or birth weight ≥20 weeks or ≥500 g Yes
USA Any signs of life regardless of gestational age or birth weight ≥20 weeks and/or ≥350 gb No
Denmark Any signs of life regardless of gestational age or birth weight ≥28 weeks till 2003 and ≥22 weeks from 2004 Yes
Finland Any signs of life regardless of gestational age or birth weight ≥22 weeks or ≥500 g No
Iceland Any signs of life regardless of gestational age or birth weight ≥22 weeks or ≥500 g Yes
Norway ≥16 weeks ≥16 weeks Noc
Sweden Any signs of life regardless of gestational age or birth weighte ≥28 weeks Yes
aIf stillbirth definition is satisfied
bA few states in the US report fetal deaths for all periods of gestation
cIn Norway, pregnancy terminations ≥16 weeks were reported as stillbirths prior to 1999 and reported on a special form since 1999 Sweden did not report
stillbirths <28 weeks until 2008
eData set provided by Swedish birth register only included live births from 154 days (22 completed weeks)
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at <22 weeks and <500 g. However, the United States had
significantly lower stillbirth ratios than Canada, Finland,
Iceland and Norway in the other preterm gestational age
categories and in other birth weight categories <1,500 g
(Table 4). Exclusion of births <28 weeks attenuated but did
not eliminate the differences between Canada and the
United States versus Finland.
Contrasts of crude neonatal mortality rates in 2005
showed that Canadian rates were 83 % (95 % CI 71–96)
higher and U.S. rates were 96 % (95 % CI 93–99) higher
than those in Finland (Table 5). Denmark had a signifi-
cantly higher neonatal mortality rate (rate ratio 1.55) than
Finland, while Sweden had a significantly lower rate (rate
ratio 0.67). When live births <22 weeks gestation and live
births <24 weeks were excluded from calculations of neo-
natal mortality, the differences between Canada and the
United States versus Finland were substantially attenuated.
Canadian neonatal mortality rates in 2005 among live
Table 2 Distribution of live births by gestational age (GA) and birth weight (BW) among selected high-income countries, 1995–2005
Gestational age/Birth
weight
Canada USA Denmark Finland Iceland Norway Sweden
Number (%) Number (%) Number (%) Number (%) Number (%) Number (%) Number (%)
GA (weeks) <22 1,494 33,691 64 6 0 101 not reported
(0.07) (0.08) (0.01) (0.001) (0.00) (0.02)
22–23 1,902 58,438 174 175 21 272 335
(0.08) (0.13) (0.02) (0.03) (0.05) (0.04) (0.03)
24–25 2,774 90,104 637 308 47 666 1,056
(0.12) (0.21) (0.09) (0.05) (0.10) (0.11) (0.10)
26–27 3,982 115,727 1,122 477 61 1,050 1,633
(0.17) (0.27) (0.16) (0.08) (0.13) (0.17) (0.16)
28–31 14,820 428,298 4,927 3,510 265 4,486 6,628
(0.65) (0.98) (0.68) (0.56) (0.57) (0.73) (0.64)
32–36 146,954 3,825,597 39,283 28,953 2,099 35,881 55,058
(6.40) (8.78) (5.44) (4.59) (4.55) (5.82) (5.35)
37–41 2,093,277 37,425,755 618,667 568,932 40,625 516,860 882,169
(91.1) (85.9) (85.7) (90.2) (88.1) (83.8) (85.8)
≥42 32,197 1,595,445 57,135 28,180 2,992 57,565 81,697
(1.40) (3.66) (7.91) (4.47) (6.49) (9.33) (7.94)
Unknown 5,699 432,844 6,642 5,369 199 25,258 1,273
(0.25) (0.98) (0.91) (0.84) (0.43) (3.93) (0.12)
BW (grams) <500 2,315 60,211 158 166 6 255 185
(0.10) (0.14) (0.02) (0.03) (0.01) (0.04) (0.02)
500–749 3,790 120,794 742 751 60 898 1,059
(0.16) (0.27) (0.10) (0.12) (0.13) (0.14) (0.10)
750–999 4,228 128,551 1,250 920 80 1,224 1,672
(0.18) (0.29) (0.17) (0.14) (0.17) (0.19) (0.16)
1,000–1,499 11,584 319,100 4,015 2,745 215 3,561 4,689
(0.50) (0.73) (0.56) (0.43) (0.46) (0.56) (0.46)
1,500–1,999 25,331 666,492 8,240 5,590 380 6,852 9,249
(1.10) (1.52) (1.14) (0.88) (0.82) (1.07) (0.90)
≥2000 2,250,300 42,694,623 707,730 624,694 45,563 628,658 1,008,332
(97.9) (97.1) (98.0) (98.4) (98.4) (98.0) (98.4)
Unknown 5,551 16,128 6,516 1,044 5 691 4,663
(0.24) (0.04) (0.89) (0.16) (0.01) (0.11) (0.45)
Total 2,303,099
(100.0)
44,005,899
(100.0)
728,651
(100.0)
635,910
(100.0)
46,309
(100.0)
642,139
(100.0)
1,029,849
(100.0)
Percentages calculated after excluding live births with unknown gestational age or birth weight (except for total and unknown cells)
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births ≥28 weeks were 14 % (95 % CI 4–23) lower than
rates in Finland, while the same rates in the United States
were 9 % (95 % CI 7–11) lower than those in Finland.
Neonatal mortality rates in Denmark and Sweden relative
to Finland were not similarly affected by the exclusion of
live births <28 weeks. Contrasts of neonatal mortality rates
calculated after excluding live births <500 g and <1,000 g
birth weight showed a similar pattern (Table 5).
Between-country comparisons of crude stillbirth
rates showed that Norway, the United States, and
Canada had the highest rates (Appendix 1 Table 7).
In 2005, Norway had a crude stillbirth rate that was
145 % (95 % CI 123–169) higher than Finland’s. Com-
parisons restricted to births ≥28 weeks rendered this
difference non-significant (rate ratio 0.95, 95 % CI
0.80–1.12).
Table 3 Neonatal mortality rates by gestational age (GA) and birth weight (BW) among selected high-income countries, 1995–2005
Gestational
age/Birth weight
Canada USA Denmark Finland Iceland Norway Sweden
Rate Rate Rate Rate Rate Rate Rate
(95 % CI) (95 % CI) (95 % CI) (95 % CI) (95 % CI) (95 % CI) (95 % CI)
GA (weeks) <22 950.5 850.9 875.0 1000.0 0.0 950.5 -a
(938.2–960.9) (847.0–854.6) (768.5–944.5) (540.7–1000.0) (0.0–0.0) (888.2–983.7)
22–23 892.2 724.1 879.3 794.3 1000.0 739.0 561.2
(877.4–905.8) (720.4–727.7) (821.4–923.7) (726.8–851.6) (857.5–1000.0) (682.5–790.1) (506.2–615.1)
24–25 417.4 311.7 456.8 318.2 340.4 304.8 269.9
(399.0–436.1) (308.6–314.7) (417.6–496.4) (266.5–373.4) (208.6–493.1) (270.0–341.3) (243.3–297.8)
26–27 141.9 118.1 181.8 136.3 131.1 106.7 140.2
(131.2–153.1) (116.3–120.0) (159.7–205.7) (106.8–170.4) (58.4–242.2) (88.6–126.9) (123.7–158.0)
28–31 44.4 36.5 43.8 46.2 34.0 38.1 42.2
(41.1–47.8) (35.9–37.1) (38.3–49.9) (39.5–53.6) (15.6–63.5) (32.7–44.1) (37.5–47.4)
32–36 7.0 5.9 7.9 8.5 7.6 6.9 8.6
(6.6–7.4) (5.9–6.0) (7.0–8.8) (7.4–9.6) (4.4–12.3) (6.0–7.8) (7.8–9.4)
37–41 0.9 0.9 1.3 0.9 0.5 1.0 0.8
(0.9–0.9) (0.9–0.9) (1.2–1.4) (0.8–0.9) (0.3–0.8) (0.9–1.0) (0.7–0.9)
≥42 1.3 1.1 1.6 1.1 0.7 1.1 1.2
(0.9–1.7) (1.0–1.1) (1.3–1.9) (0.7–1.5) (0.1–2.4) (0.8–1.4) (1.0–1.5)
Unknown 32.3 13.0 61.0 67.8 0.0 4.3 33.8
(27.9–37.2) (12.7–13.3) (55.3–67.0) (61.2–74.9) (0.0–18.4) (3.5–5.2) (24.6–45.2)
BW (grams) <500 914.0 838.3 905.1 795.2 833.3 760.8 578.4
(901.9–925.1) (835.4–841.3) (848.3–945.9) (725.7–853.8) (358.8–995.8) (703.6–811.8) (503.7–650.5)
500–749 533.8 420.8 481.1 472.7 633.3 368.6 330.5
(517.7–549.8) (418.1–423.6) (444.6–517.8) (436.5–509.1) (499.0–754.1) (337.0–401.1) (302.2–359.7)
750–999 163.9 118.4 175.2 162.0 150.0 111.1 112.4
(152.9–175.4) (116.7–120.2) (154.5–197.4) (138.7–187.4) (80.0–247.4) (94.0–130.1) (97.7–128.6)
1,000–1,499 53.4 42.4 61.0 51.4 18.6 45.5 52.2
(49.4–57.7) (41.7–43.1) (53.8–68.9) (43.2–60.6) (5.1–46.9) (38.9–52.9) (46.1–59.0)
1,500–1,999 19.7 18.3 22.5 23.8 10.5 16.2 21.5
(18.1–21.5) (18.0–18.6) (19.4–25.9) (20.0–28.1) (2.9–26.7) (13.3–19.5) (18.7–24.7)
≥2000 1.1 1.2 1.3 1.1 0.8 1.1 0.9
(1.1–1.1) (1.1–1.2) (1.3–1.4) (1.0–1.2) (0.5–1.1) (1.0–1.2) (0.9–1.0)
Unknown 36.4 135.4 66.0 12.5 0.0 94.1 55.8
(31.6–41.7) (130.2–140.8) (60.1–72.3) (6.6–21.2) (0.0–521.8) (73.3–118.3) (49.3–62.7)
Total 3.8 4.4 3.5 2.5 2.1 2.6 2.2
(3.7–3.8) (4.4–4.4) (3.3–3.6) (2.4–2.6) (1.7–2.6) (2.5–2.8) (2.1–2.3)
Rates expressed per 1,000 live births. aLive births <22 weeks not recorded in the Swedish Medical Birth Register
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Table 4 Stillbirth to live birth ratios, by gestational age (GA) and birth weight (BW) among selected high-income countries, 1995–2005
Gestational age/Birth weight Canada USA Denmark Finland Iceland Norway Sweden
Ratio (95 % CI) Ratio (95 % CI) Ratio (95 % CI) Ratio (95 % CI) Ratio (95 % CI) Ratio (95 % CI) Ratio (95 % CI)
GA (weeks) <22 155.8 (145.9–166.4) 163.6 (161.4–165.9) -a 200.0 (69.5–649.6) - 2073.3 (1698.6–2559.6) -a
22–23 112.1 (105.3–119.3) 79.2 (78.3–80.2) - 90.8 (72.8–113.3) 176.2 (100.5–316.8) 173.9 (149.5–202.6) -
24–25 38.2 (35.6–41.0) 26.7 (26.3–27.1) - 37.0 (29.6–46.0) 42.6 (23.9–73.2) 40.7 (35.2–46.9) -
26–27 18.2 (16.8–19.7) 15.3 (15.0–15.5) - 23.5 (18.9–28.9) 23.0 (11.9–41.5) 20.1 (17.2–23.3) -
28–31 9.6 (9.1–10.1) 7.6 (7.5–7.7) 11.4 (10.4–12.4) 9.4 (8.3–10.5) 10.9 (7.2–16.1) 8.6 (7.7–9.6) 9.2 (8.5–10.0)
32–36 1.7 (1.6–1.7) 1.3 (1.3–1.3) 2.0 (1.9–2.2) 1.6 (1.5–1.7) 2.0 (1.4–2.7) 1.7 (1.6–1.9) 1.9 (1.8–2.0)
37–41 0.2 (0.2–0.2) 0.1 (0.1–0.1) 0.2 (0.2–0.3) 0.1 (0.1–0.1) 0.1 (0.1–0.2) 0.2 (0.2–0.2) 0.2 (0.2–0.2)
≥42 0.2 (0.1–0.2) 0.1 (0.1–0.1) 0.2 (0.2–0.2) 0.1 (0.0–0.1) 0.0 (0.0–0.2) 0.2 (0.2–0.2) 0.2 (0.2–0.2)
Unknown 2.4 (2.1–2.9) 7.0 (7.0–7.1) 1.3 (1.1–1.6) 10.1 (9.2–11.0) 0.0 (0.0–1.9) 2.3 (2.1–2.5) 2.1 (1.4–3.1)
BW (grams) <500 128.6 (121.7–135.8) 139.4 (137.9–140.8) 51.3 (38.7–67.4) 196.4 (162.4–238.2) 383.3 (151.8–1151.6) 1077.9 (947.1–1229.8) 13.5 (8.5–20.6)
500–749 59.5 (56.4–62.7) 32.7 (32.3–33.1) 18.5 (15.3–22.2) 47.0 (41.3–53.4) 71.7 (47.3–107.8) 54.7 (48.9–61.1) 9.6 (7.8–11.8)
750–999 22.0 (20.5–23.6) 13.8 (13.5–14.0) 11.4 (9.6–13.6) 21.1 (18.0–24.6) 21.3 (11.8–36.2) 16.8 (14.4–19.4) 8.6 (7.2–10.1)
1,000–1,499 9.7 (9.1–10.3) 7.5 (7.4–7.6) 7.6 (6.7–8.5) 9.5 (8.3–10.8) 12.1 (7.7–18.2) 8.3 (7.3–9.3) 8.4 (7.6–9.3)
1,500–1,999 4.2 (4.0–4.5) 3.3 (3.2–3.3) 3.8 (3.4–4.2) 4.3 (3.8–4.9) 2.4 (1.1–4.5) 3.8 (3.4–4.3) 4.5 (4.1–5.0)
≥2000 0.2 (0.2–0.2) 0.2 (0.2–0.2) 0.3 (0.2–0.3) 0.2 (0.2–0.2) 0.2 (0.1–0.2) 0.2 (0.2–0.2) 0.2 (0.2–0.3)
Unknown 15.8 (14.7–17.0) 308.0 (302.4–313.4) 7.3 (6.7–8.0) 4.7 (3.4–6.2) 0.0 (0.0–109.1) 48.0 (42.0–54.8) 2.5 (2.0–3.0)
Total 0.6 (0.6–0.6) 0.7 (0.7–0.7) 0.4 (0.4–0.5) 0.4 (0.4–0.4) 0.4 (0.4–0.5) 0.9 (0.9–0.9) 0.4 (0.3–0.4)
Ratios are expressed per 100 live births
aDenmark and Sweden did not report stillbirths <28 weeks until 2004 and 2008, respectively
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Table 5 Crude neonatal mortality rates and rate ratios, and neonatal mortality rates and rate ratios after excluding live births <22 weeks, <24 weeks and <28 weeks, among
selected high-income countries, 1995–2005 and 2005
Gestational age/Birth weight 1995-2005 2005
Rate (95 % CI) Rate Ratio (95 % CI) Rate (95 % CI) Rate Ratio (95 % CI)
GA (weeks) ≥22 Canada 3.1 (3.1–3.2) 1.26 (1.23–1.29) 3.2 (2.9–3.4) 1.47 (1.36–1.59)
USA 3.8 (3.7–3.8) 1.50 (1.49–1.51) 3.5 (3.5–3.6) 1.65 (1.62–1.67)
Denmark 3.4 (3.3–3.5) 1.35 (1.30–1.41) 3.3 (2.8–3.7) 1.51 (1.32–1.73)
Finland 2.5 (2.4–2.6) 1.00 2.2 (1.8–2.6) 1.00
Iceland 2.1 (1.7–2.5) 0.83 (0.67–1.01) 1.4 (0.5–3.0) 0.65 (0.24–1.41)
Norway 2.4 (2.3–2.5) 0.97 (0.92–1.02) 1.9 (1.5–2.3) 0.87 (0.72–1.06)
Sweden 2.2 (2.1–2.3) 0.89 (0.86–0.93) 1.4 (1.2–1.7) 0.67 (0.57–0.79)
≥24 Canada 2.4 (2.3–2.5) 1.05 (1.03–1.08) 2.4 (2.2–2.7) 1.24 (1.14–1.36)
USA 2.8 (2.8–2.8) 1.22 (1.22–1.23) 2.6 (2.5–2.6) 1.32 (1.30–1.35)
Denmark 3.2 (3.0–3.3) 1.39 (1.34–1.45) 3.0 (2.6–3.4) 1.53 (1.32–1.76)
Finland 2.3 (2.2–2.4) 1.00 2.0 (1.6–2.4) 1.00
Iceland 1.6 (1.2–2.0) 0.68 (0.53–0.86) 0.9 (0.3–2.4) 0.48 (0.13–1.22)
Norway 2.1 (2.0–2.2) 0.92 (0.87–0.97) 1.5 (1.2–1.9) 0.79 (0.63–0.97)
Sweden 2.0 (2.0–2.1) 0.90 (0.86–0.94) 1.4 (1.1–1.6) 0.70 (0.58–0.82)
≥28 Canada 1.7 (1.6–1.7) 0.82 (0.79–0.85) 1.6 (1.4–1.7) 0.86 (0.77–0.96)
USA 1.9 (1.8–1.9) 0.91 (0.91–0.92) 1.7 (1.6–1.7) 0.91 (0.89–0.93)
Denmark 2.5 (2.4–2.6) 1.23 (1.18–1.29) 2.2 (1.9–2.6) 1.22 (1.03–1.43)
Finland 2.0 (1.9–2.1) 1.00 1.8 (1.5–2.2) 1.00
Iceland 1.0 (0.8–1.4) 0.51 (0.38–0.68) 0.5 (0.1–1.7) 0.26 (0.03–0.92)
Norway 1.6 (1.5–1.7) 0.78 (0.73–0.83) 1.2 (1.0–1.6) 0.67 (0.52–0.85)
Sweden 1.6 (1.5–1.6) 0.77 (0.73–0.81) 1.0 (0.8–1.2) 0.53 (0.43–0.65)
BW (grams) ≥500 Canada 2.8 (2.8–2.9) 1.23 (1.21–1.27) 2.7 (2.5–3.0) 1.40 (1.29–1.52)
USA 3.3 (3.2–3.3) 1.42 (1.41–1.42) 3.0 (3.0–3.1) 1.53 (1.51–1.57)
Denmark 3.3 (3.1–3.4) 1.42 (1.36–1.48) 3.1 (2.7–3.5) 1.56 (1.35–1.79)
Finland 2.3 (2.2–2.4) 1.00 2.0 (1.6–2.4) 1.00
Iceland 2.0 (1.6–2.5) 0.87 (0.70–1.07) 1.2 (0.4–2.7) 0.59 (0.19–1.39)
Norway 2.2 (2.1–2.4) 0.97 (0.92–1.02) 1.7 (1.4–2.1) 0.87 (0.71–1.07)
Sweden 2.1 (2.0–2.2) 0.92 (0.89–0.96) 1.4 (1.2–1.6) 0.71 (0.59–0.83)
≥1000 Canada 1.7 (1.6–1.7) 1.10 (1.07–1.14) 1.4 (1.3–1.6) 1.04 (0.93–1.17)
USA 1.8 (1.8–1.8) 1.17 (1.16–1.18) 1.6 (1.6–1.6) 1.18 (1.15–1.21)
Denmark 2.5 (2.4–2.6) 1.64 (1.57–1.72) 2.3 (1.9–2.7) 1.67 (1.41–1.97)
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Table 5 Crude neonatal mortality rates and rate ratios, and neonatal mortality rates and rate ratios after excluding live births <22 weeks, <24 weeks and <28 weeks, among
selected high-income countries, 1995–2005 and 2005 (Continued)
Finland 1.5 (1.4–1.6) 1.00 1.4 (1.1–1.7) 1.00
Iceland 0.9 (0.7–1.3) 0.62 (0.45–0.83) 0.5 (0.1–1.7) 0.34 (0.04–1.24)
Norway 1.5 (1.4–1.6) 1.00 (0.94–1.06) 1.2 (1.0–1.6) 0.92 (0.72–1.16)
Sweden 1.6 (1.5–1.7) 1.06 (1.01–1.12) 1.0 (0.8–1.2) 0.75 (0.61–0.91)
All live births Canada 3.8 (3.7–3.8) 1.50 (1.47–1.53) 3.9 (3.7–4.2) 1.83 (1.71–1.96)
USAa 4.4 (4.4–4.4) 1.76 (1.75–1.76) 4.2 (4.2–4.3) 1.96 (1.93–1.99)
Denmark 3.5 (3.3–3.6) 1.38 (1.33–1.43) 3.3 (2.9–3.8) 1.55 (1.35–1.77)
Finland 2.5 (2.4–2.6) 1.00 2.2 (1.8–2.6) 1.00
Iceland 2.1 (1.7–2.6) 0.84 (0.69–1.03) 1.4 (0.5–3.1) 0.65 (0.24–1.41)
Norway 2.6 (2.5–2.8) 1.05 (1.00–1.10) 2.1 (1.7–2.5) 0.96 (0.79–1.15)
Sweden 2.2 (2.1–2.3) 0.89 (0.85–0.93) 1.4 (1.2–1.7) 0.67 (0.57–0.79)
GA gestational age and BW birth weight. Rates are expressed per 1,000 infants at risk. Only births with gestational age <22 weeks excluded from the rate calculation for births ≥22 weeks i.e., births with unknown
gestational age included in the calculations. Calculations of rates for births ≥28 weeks and birth weight ≥500 g and ≥1000 g were carried out in a similar manner. Finland was used as the reference category for
calculation of rate ratios
aUS rates are based on live births with GA ≥20 completed weeks
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Table 6 shows crude, gestational age-specific and birth
weight-specific post-neonatal mortality rates. Compared
with Finland, crude rates of post-neonatal mortality in
2005 were 54 % (95 % CI 36–73) higher in Canada and
160 % (95 % CI 154–165) higher in the United States.
Gestational age-specific comparisons after restriction to
live births ≥22 weeks and ≥28 weeks did not significantly
attenuate the differences between Canada and the
United States versus Finland.
Analyses of gestational age—and birth weight-specific
perinatal and feto-infant mortality showed similar results
(Appendix 2 Table 8 and Appendix 3 Table 9). Compari-
sons of cause-specific infant mortality rates for the period
of 1995–2005 showed that infant deaths due to congenital
anomalies, immaturity and other causes were all higher in
Canada and the United States compared with the Nordic
countries (except for Denmark, Appendix Table 4).
Discussion
The higher rates of live births <22 and 22–23 weeks ges-
tation in Canada as compared with the Nordic coun-
tries, and the lack of similar differences between them
Table 6 Crude post-neonatal mortality rates and rate ratios, and post-neonatal mortality rates and rate ratios after excluding live
births <22 weeks and <28 weeks, among selected high-income countries, 1995–2005 and 2005
Gestational age/Birth weight 1995-2005 2005
Rate (95 % CI) Rate Ratio (95 % CI) Rate (95 % CI) Rate Ratio (95 % CI)
GA (weeks) ≥22 Canada 1.6 (1.5–1.6) 1.62 (1.57–1.68) 1.4 (1.2–1.5) 1.54 (1.36–1.73)
USA 2.4 (2.3–2.4) 2.41 (2.40–2.43) 2.3 (2.3–2.3) 2.59 (2.54–2.65)
Denmark 1.2 (1.1–1.3) 1.17 (1.09–1.25) 1.0 (0.8–1.3) 1.12 (0.86–1.43)
Finland 1.0 (1.0–1.1) 1.00 0.9 (0.7–1.2) 1.00
Norway 1.1 (1.1–1.2) 1.18 (1.09–1.26) 0.7 (0.5–1.0) 0.79 (0.56–1.08)
Sweden 1.1 (1.0–1.2) 1.14 (1.07–1.21) 1.1 (0.9–1.3) 1.19 (0.98–1.44)
≥28 Canada 1.5 (1.4–1.5) 1.49 (1.44–1.54) 1.2 (1.1–1.4) 1.43 (1.26–1.61)
USA 2.1 (2.1–2.1) 2.13 (2.11–2.14) 2.0 (1.9–2.0) 2.32 (2.27–2.37)
Denmark 1.2 (1.1–1.2) 1.15 (1.07–1.23) 0.9 (0.7–1.2) 1.04 (0.79–1.35)
Finland 1.0 (0.9–1.1) 1.00 0.9 (0.6–1.1) 1.00
Norway 1.0 (1.0–1.1) 1.06 (0.98–1.15) 0.6 (0.4–0.8) 0.70 (0.48–0.98)
Sweden 1.0 (0.9–1.1) 1.03 (0.96–1.09) 0.9 (0.7–1.1) 1.07 (0.86–1.31)
BW (grams) ≥500 Canada 1.6 (1.5–1.6) 1.57 (1.52–1.62) 1.4 (1.2–1.5) 1.53 (1.36–1.72)
USA 2.3 (2.3–2.3) 2.32 (2.30–2.33) 2.3 (2.2–2.3) 2.56 (2.51–2.61)
Denmark 1.2 (1.1–1.3) 1.18 (1.10–1.26) 1.0 (0.8–1.3) 1.12 (0.86–1.42)
Finland 1.0 (0.9–1.1) 1.00 0.9 (0.7–1.2) 1.00
Norway 1.1 (1.1–1.2) 1.13 (1.05–1.22) 0.7 (0.5–0.9) 0.77 (0.55–1.05)
Sweden 1.1 (1.0–1.2) 1.10 (1.04–1.16) 1.0 (0.9–1.3) 1.18 (0.97–1.43)
≥1000 Canada 1.5 (1.4–1.5) 1.51 (1.46–1.57) 1.2 (1.0–1.3) 1.52 (1.33–1.72)
USA 2.0 (2.0–2.1) 2.13 (2.12–2.14) 1.9 (1.9–2.0) 2.48 (2.43–2.54)
Denmark 1.1 (1.1–1.2) 1.20 (1.12–1.28) 0.9 (0.7–1.2) 1.00 (0.76–1.30)
Finland 1.0 (0.9–1.0) 1.00 0.8 (0.6–1.0) 1.00
Norway 1.0 (1.0–1.1) 1.09 (1.01–1.18) 0.6 (0.4–0.8) 0.76 (0.53–1.06)
Sweden 1.0 (0.9–1.1) 1.04 (0.98–1.11) 0.9 (0.7–1.1) 1.16 (0.93–1.42)
All live births Canada 1.6 (1.5–1.6) 1.57 (1.52–1.62) 1.4 (1.2–1.5) 1.54 (1.36–1.73)
USA 2.4 (2.3–2.4) 2.34 (2.32–2.35) 2.3 (2.3–2.3) 2.60 (2.54–2.65)
Denmark 1.2 (1.1–1.3) 1.17 (1.09–1.25) 1.0 (0.8–1.3) 1.12 (0.86–1.43)
Finland 1.0 (0.9–1.1) 1.00 0.9 (0.7–1.2) 1.00
Norway 1.1 (1.1–1.2) 1.14 (1.06–1.22) 0.7 (0.5–1.0) 0.79 (0.56–1.08)
Sweden 1.1 (1.0–1.2) 1.10 (1.04–1.17) 1.1 (0.9–1.3) 1.19 (0.98–1.44)
GA gestational age and BW birth weight. Rates are expressed per 1,000 infants at risk. Only births with gestational age <22 weeks excluded from the rate
calculation for births ≥22 weeks i.e., births with unknown gestational age included in the calculations. Calculations of rates for births ≥28 weeks and birth weight
≥500 g and ≥1000 g were carried out in a similar manner. Finland was used as the reference category for calculation of rate ratios
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in live birth frequency at 24–25, 26–27 and 28–31
weeks and at 750–999 g, 1000–1499 g and 1500–1999 g
suggests that the former differences may reflect dissimi-
larities in birth registration [18–20]. The observed dif-
ferences in stillbirth and neonatal mortality may be a
consequence of artifactual differences in birth registra-
tion. The unexpectedly low neonatal mortality rate among
live births at 22–23 weeks gestation in Sweden may suggest
the possibility of selective birth registration of survivors.
The lower stillbirth:live birth ratios in the United States at
22–23 weeks and other preterm gestations may reflect a
tendency to label non-viable live births as stillbirths.
Between-country differences in crude versus gestational
age-specific stillbirth and neonatal mortality rates may also
stem from differences in birth registration. This is exempli-
fied by the stillbirth contrast between Norway and Finland.
Norway (which registered stillbirths from 16 week gesta-
tion) had substantially higher crude stillbirth rates com-
pared with Finland (stillbirth registration criteria ≥22 weeks
or ≥500 g), whereas no significant difference was observed
after restriction to births ≥500 g, ≥1,000 g or ≥28 weeks. Fi-
nally, the lack of difference in crude versus gestational
age—and birth weight-specific comparisons of post-
neonatal mortality probably reflect the fact that near-viable
births do not contribute substantially to post-neonatal
deaths. The higher rates of post-neonatal mortality in
Canada and the United States can be best explained by
differences in factors such as the level of community-
based social supports, preventative medical follow-up,
strict surveillance for vaccination etc.
Our findings may indicate true differences in perinatal
and postnatal health status between countries. We are not
aware of any reports that non-viable live births are regis-
tered as stillbirths or labeled as miscarriages in the Nordic
countries. In fact, a tendency to register live births <500 g
as stillbirths has been reported from a few U.S. states [21].
The high rate of preterm birth in the United States relative
to the Nordic countries is congruent with true differences
in determinants of preterm birth such as body mass index,
smoking, teen pregnancy and socioeconomic status. These
factors could also explain higher live birth rates at very
early gestation in the United States [22, 23].
Other explanations for our findings include between-
country differences in stillbirth definitions including the
exclusion of fetal deaths following pregnancy termination
from stillbirth counts [24, 25] (Table 1). Finally, methods
of estimation of gestational age vary between countries
and need to be considered when comparing mortality
rates. While ultrasound is considered the optimal method,
combinations of last menstrual period, clinical estimates
and ultrasound are often used.. These between-country
differences in gestational age ascertainment may underlie
some observed differences in mortality [14, 26]. For in-
stance, misclassification due to the primary use of
menstrual dating in the United States data may explain
the slightly lower neonatal mortality rates at 22–23 weeks.
The routine use of early ultrasound dating in Sweden,
however, cannot explain the unexpectedly low neonatal
mortality at 22–23 weeks.Our study has several limita-
tions. We could not use data beyond 2005 since Canadian
birth-death linked data were unavailable beyond 2005.
Large datasets such as the ones we used are likely to con-
tain errors. Systematic reporting differences can occur even
within countries: for 2005, the CDC reported a neonatal
mortality rate of 4.54 per 1000 live births based on all live
births without any exclusion [27], while our estimated rate
of 4.2 for the same year was based on live births with ≥20
completed weeks’ gestation. Errors in gestational age esti-
mation are more likely at extremely low gestation. Correc-
tion of such errors differs by country. Some countries
attempt to improve data quality by excluding very early ges-
tation births with birth weight-for-gestational-age (z-score)
above a certain threshold; infant mortality rates may change
depending on whether or not such data checks are carried
out, whether the gestational age of such births is set to
missing and whether or not such births are deleted from
vital records.
Conclusions
Our study shows substantial international variation in
the frequency and mortality of near-viable births. Rea-
sons to suspect that the observed variations are artifacts
of birth registration differences include similar live birth
frequencies in other very preterm/low birth weight cat-
egories, some implausibly low neonatal mortality rates at
the borderline of viability, large between-country differ-
ences in stillbirth ratios at very preterm gestation, and
differences in between-country contrasts of crude versus
gestational age—and birth weight-specific stillbirths and
neonatal mortality. On the other hand, true between-
country differences in maternal, fetal and infant health
status could also explain the observed findings; particu-
larly for post-neonatal mortality. The distribution of risk
factors for preterm birth in different countries and the high
rates of preterm birth in the United States relative to the
Nordic countries are congruent with the observed higher
rates of live births at the borderline of viability in the
United States. Also, discrepancies in birth registration (la-
beling nonviable live births as stillbirths) have been re-
ported from the United States but not from the Nordic
countries. Our study cannot provide a definitive explan-
ation for the observed differences in the frequency and
mortality of live births at the borderline of viability and at
very early gestation. More detailed studies are required to
assess the value of international comparisons of fetal and
infant mortality and to make such comparisons more
meaningful.
Deb-Rinker et al. BMC Pediatrics  (2015) 15:112 Page 10 of 15
Appendix 1
Table 7 Crude stillbirth rates and rate ratios, and stillbirth rates and rate ratios after excluding live births and stillbirths <22 weeks
and <28 weeks, among selected high-income countries, 1995-2005 and 2005
Gestational age/Birth weight 1995–2005 2005
Rate (95 % CI) Rate Ratio (95 % CI) Rate (95 % CI) Rate Ratio (95 % CI)
GA (weeks) ≥22 Canada 4.8 (4.7–4.9) 1.27 (1.24–1.29) 5.0 (4.7–5.3) 1.55 (1.45–1.64)
USA 5.7 (5.7–5.8) 1.50 (1.49–1.51) 5.4 (5.4–5.5) 1.70 (1.68–1.72)
Denmarka 4.4 (4.2–4.5) 1.14 (1.10–1.18) 4.8 (4.3–5.4) 1.51 (1.35–1.69)
Finland 3.8 (3.7–4.0) 1.00 3.2 (2.8–3.7) 1.00
Iceland 4.3 (3.7–4.9) 1.12 (0.97–1.29) 4.9 (3.0–7.4) 1.52 (0.94–2.33)
Norway 5.0 (4.8–5.2) 1.31 (1.26–1.35) 3.7 (3.2–4.3) 1.17 (1.01–1.33)
Swedena 3.4 (3.3–3.6) 0.90 (0.87–0.93) 2.9 (2.6–3.3) 0.92 (0.81–1.03)
≥28 Canada 3.2 (3.1–3.2) 0.98 (0.96–1.00) 3.0 (2.7–3.2) 1.13 (1.05–1.23)
USA 3.8 (3.8–3.8) 1.17 (1.16–1.18) 3.5 (3.5–3.6) 1.34 (1.32–1.36)
Denmark 4.1 (4.0–4.3) 1.29 (1.24–1.33) 3.4 (3.0–3.9) 1.32 (1.15–1.50)
Finland 3.2 (3.1–3.4) 1.00 2.6 (2.2–3.1) 1.00
Iceland 2.8 (2.3–3.3) 0.85 (0.71–1.02) 1.4 (0.5–3.0) 0.53 (0.20–1.16)
Norway 3.5 (3.3–3.6) 1.07 (1.03–1.12) 2.5 (2.1–2.9) 0.95 (0.80–1.12)
Sweden 3.5 (3.3–3.6) 1.07 (1.04–1.11) 2.9 (2.6–3.3) 1.12 (1.00–1.26)
BW (grams) ≥500 Canada 4.6 (4.5–4.6) 1.37 (1.34–1.39) 4.4 (4.1–4.7) 1.60 (1.49–1.70)
USA 5.1 (5.1–5.1) 1.53 (1.52–1.53) 4.8 (4.7–4.9) 1.74 (1.71–1.76)
Denmark 4.3 (4.1–4.4) 1.28 (1.23–1.32) 4.4 (3.9–4.9) 1.58 (1.40–1.77)
Finland 3.3 (3.2–3.5) 1.00 2.8 (2.4–3.2) 1.00
Iceland 3.8 (3.2–4.4) 1.14 (0.98–1.32) 3.5 (1.9–5.7) 1.26 (0.70–2.07)
Norway 4.2 (4.0–4.3) 1.26 (1.21–1.30) 3.1 (2.6–3.6) 1.11 (0.96–1.29)
Sweden 3.5 (3.4–3.6) 1.04 (1.01–1.08) 2.9 (2.6–3.2) 1.04 (0.92–1.17)
≥1000 Canada 3.2 (3.1–3.3) 1.29 (1.26–1.32) 2.9 (2.7–3.1) 1.36 (1.25–1.47)
USA 3.8 (3.8–3.8) 1.54 (1.53–1.55) 3.6 (3.6–3.7) 1.71 (1.68–1.74)
Denmark 3.9 (3.7–4.0) 1.57 (1.51–1.62) 3.5 (3.0–4.0) 1.65 (1.44–1.88)
Finland 2.5 (2.4–2.6) 1.00 2.1 (1.8–2.5) 1.00
Iceland 2.5 (2.1–3.0) 1.01 (0.83–1.21) 1.4 (0.5–3.0) 0.66 (0.24–1.44)
Norway 3.1 (3.0–3.3) 1.25 (1.20–1.31) 2.4 (2.0–2.8) 1.12 (0.94–1.33)
Sweden 3.2 (3.1–3.4) 1.31 (1.26–1.35) 2.7 (2.4–3.1) 1.28 (1.14–1.44)
All births Canada 5.8 (5.7–5.9) 1.52 (1.49–1.55) 6.2 (5.9–6.6) 1.93 (1.83–2.04)
USA 7.0 (6.9–7.0) 1.81 (1.81–1.82) 6.7 (6.6–6.8) 2.08 (2.06–2.11)
Denmark 4.4 (4.2–4.5) 1.14 (1.10–1.18) 4.8 (4.3–5.4) 1.50 (1.34–1.68)
Finland 3.8 (3.7–4.0) 1.00 3.2 (2.8–3.7) 1.00
Iceland 4.3 (3.7–4.9) 1.11 (0.97–1.28) 4.9 (3.0–7.4) 1.51 (0.94–2.31)
Norway 8.9 (8.7–9.1) 2.32 (2.26–2.38) 7.9 (7.2–8.6) 2.45 (2.23–2.69)
Sweden 3.5 (3.4–3.6) 0.91 (0.88–0.94) 2.9 (2.6–3.3) 0.91 (0.81–1.02)
Rates are expressed per 1,000 total births
aDenmark and Sweden did not report stillbirths less than 28 weeks until 2004 and 2008, respectively
Only births with gestational age <22 weeks excluded from the rate calculation for births ≥22 weeks i.e., births with unknown gestational age included in the
calculations. Calculations of rates for births ≥28 weeks and birth weight ≥500 g and ≥1000 g were carried out in a similar manner. Finland was used as the
reference category for calculation of rate ratios
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Appendix 2
Table 8 Perinatal mortality rates and rate ratios by gestational age (GA) and birth weight (BW) among selected high-income countries,
1995–2005 and 2005
Gestational age/Birth weight 1995–2005 2005
Rate ( 95 % CI) Rate Ratio ( 95 % CI) Rate ( 95 % CI) Rate Ratio ( 95 % CI)
GA (weeks) ≥22 Canada 8.0 (7.9–8.1) 1.26 (1.24–1.28) 8.1 (7.7–8.5) 1.52 (1.45–1.60)
USA 9.5 (9.4–9.5) 1.50 (1.50–1.50) 9.0 (8.9–9.1) 1.68 (1.67–1.70)
Denmarka 7.7 (7.5–7.9) 1.23 (1.19–1.26) 8.1 (7.4–8.8) 1.51 (1.38–1.64)
Finland 6.3 (6.1–6.5) 1.00 5.3 (4.8–6.0) 1.00
Iceland 6.3 (5.6–7.1) 1.01 (0.89–1.13) 6.3 (4.1–9.1) 1.17 (0.77–1.71)
Norway 7.4 (7.2–7.6) 1.17 (1.14–1.21) 5.6 (5.0–6.2) 1.05 (0.94–1.17)
Swedena 5.7 (5.5–5.8) 0.90 (0.88–0.92) 4.4 (4.0–4.8) 0.82 (0.75–0.90)
≥28 Canada 4.8 (4.7–4.9) 0.92 (0.90–0.94) 4.5 (4.2–4.8) 1.02 (0.95–1.08)
USA 5.6 (5.6–5.6) 1.07 (1.07–1.08) 5.2 (5.1–5.2) 1.16 (1.14–1.17)
Denmark 6.6 (6.5–6.8) 1.27 (1.23–1.30) 5.7 (5.1–6.3) 1.27 (1.15–1.41)
Finland 5.2 (5.1–5.4) 1.00 4.5 (3.9–5.0) 1.00
Iceland 3.8 (3.3–4.4) 0.73 (0.62–0.84) 1.9 (0.8–3.7) 0.42 (0.18–0.83)
Norway 5.0 (4.9–5.2) 0.96 (0.93–1.00) 3.7 (3.2–4.2) 0.83 (0.72–0.95)
Sweden 5.0 (4.9–5.1) 0.96 (0.93–0.98) 3.9 (3.5–4.3) 0.88 (0.79–0.97)
BW (grams) ≥500 Canada 7.4 (7.3–7.5) 1.31 (1.29–1.33) 7.2 (6.8–7.5) 1.51 (1.44–1.59)
USA 8.3 (8.3–8.4) 1.48 (1.48–1.49) 7.8 (7.7–7.9) 1.65 (1.63–1.67)
Denmark 7.5 (7.3–7.7) 1.33 (1.30–1.37) 7.4 (6.8–8.1) 1.57 (1.43–1.72)
Finland 5.6 (5.4–5.8) 1.00 4.7 (4.2–5.3) 1.00
Iceland 5.8 (5.1–6.5) 1.03 (0.91–1.16) 4.6 (2.8–7.2) 0.98 (0.60–1.52)
Norway 6.4 (6.2–6.6) 1.14 (1.10–1.17) 4.8 (4.3–5.4) 1.01 (0.90–1.14)
Sweden 5.6 (5.5–5.7) 0.99 (0.97–1.02) 4.3 (3.9–4.7) 0.90 (0.82–0.99)
≥1000 Canada 4.9 (4.8–4.9) 1.22 (1.19–1.24) 4.3 (4.0–4.6) 1.24 (1.16–1.33)
USA 5.6 (5.6–5.6) 1.40 (1.39–1.40) 5.2 (5.2–5.3) 1.51 (1.49–1.53)
Denmark 6.4 (6.2–6.5) 1.59 (1.55–1.64) 5.7 (5.2–6.4) 1.66 (1.49–1.83)
Finland 4.0 (3.8–4.1) 1.00 3.5 (3.0–4.0) 1.00
Iceland 3.4 (2.9–4.0) 0.86 (0.73–1.01) 1.9 (0.8–3.7) 0.54 (0.23–1.06)
Norway 4.6 (4.5–4.8) 1.16 (1.12–1.20) 3.6 (3.1–4.2) 1.04 (0.91–1.20)
Sweden 4.8 (4.7–5.0) 1.22 (1.18–1.25) 3.7 (3.4–4.1) 1.08 (0.97–1.20)
All births Canada 9.6 (9.4–9.7) 1.51 (1.49–1.53) 10.1 (9.7–10.6) 1.89 (1.81–1.97)
USA 11.3 (11.3–11.4) 1.79 (1.78–1.79) 10.9 (10.8–11.0) 2.03 (2.01–2.05)
Denmark 7.8 (7.6–8.0) 1.23 (1.20–1.26) 8.1 (7.5–8.9) 1.52 (1.39–1.65)
Finland 6.3 (6.1–6.5) 1.00 5.4 (4.8–6.0) 1.00
Iceland 6.4 (5.7–7.2) 1.01 (0.90–1.13) 6.3 (4.1–9.1) 1.17 (0.77–1.70)
Norway 11.5 (11.3–11.8) 1.82 (1.78–1.86) 9.9 (9.1–10.8) 1.85 (1.70–2.01)
Sweden 5.7 (5.6–5.9) 0.90 (0.88–0.93) 4.4 (4.0–4.8) 0.81 (0.74–0.89)
Rates are expressed per 1,000 total births. Numerator = Stillbirths + Neonatal deaths
aDenmark and Sweden did not report on stillbirths less than 28 weeks until 2004 and 2008 respectively
Finland was used as the reference category for calculation of rate ratios
Only births with gestational age <22 weeks excluded from the rate calculation for births ≥22 weeks i.e., births with unknown gestational age included in the
calculations. Calculations of rates for births ≥28 weeks and birth weight ≥500 g and ≥1000 g were carried out in a similar manner
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Appendix 3
Table 9 Feto-infant mortality rates and rate ratios by gestational age (GA) and birth weight (BW) among selected high-income countries,
1995–2005 and 2005
Gestational age/Birth weight 1995–2005 2005
Rate (95 % CI) Rate Ratio (95 % CI) Rate (95 % CI) Rate Ratio (95 % CI)
GA (weeks) ≥22 Canada 9.5 (9.4–9.7) 1.30 (1.29–1.32) 9.5 (9.0–9.9) 1.52 (1.46–1.59)
USA 11.8 (11.8–11.8) 1.61 (1.61–1.62) 11.2 (11.1–11.3) 1.81 (1.79–1.83)
Denmarka 8.9 (8.7–9.1) 1.22 (1.19–1.25) 9.1 (8.3–9.8) 1.45 (1.34–1.58)
Finland 7.3 (7.1–7.5) 1.00 6.2 (5.6–6.9) 1.00
Norway 8.5 (8.3–8.7) 1.16 (1.13–1.19) 6.3 (5.6–7.0) 1.01 (0.91–1.12)
Swedena 6.8 (6.6–6.9) 0.93 (0.91–0.95) 5.4 (5.0–5.9) 0.87 (0.80–0.95)
≥28 Canada 6.3 (6.2–6.4) 1.01 (0.99–1.02) 5.7 (5.4–6.1) 1.09 (1.03–1.15)
USA 7.7 (7.7–7.7) 1.24 (1.23–1.24) 7.1 (7.0–7.2) 1.35 (1.33–1.36)
Denmark 7.8 (7.6–8.0) 1.25 (1.22–1.28) 6.6 (5.9–7.2) 1.24 (1.12–1.36)
Finland 6.2 (6.0–6.4) 1.00 5.3 (4.7–5.9) 1.00
Norway 6.0 (5.8–6.2) 0.97 (0.94–1.00) 4.3 (3.8–4.9) 0.81 (0.71–0.92)
Sweden 6.0 (5.9–6.2) 0.97 (0.94–0.99) 4.8 (4.4–5.3) 0.91 (0.83–0.99)
BW (grams) ≥500 Canada 8.9 (8.8–9.1) 1.34 (1.33–1.37) 8.5 (8.1–8.9) 1.52 (1.45–1.59)
USA 10.6 (10.6–10.7) 1.61 (1.60–1.61) 10.1 (10.0–10.2) 1.79 (1.78–1.81)
Denmark 8.7 (8.5–8.9) 1.31 (1.28–1.34) 8.4 (7.7–9.2) 1.50 (1.38–1.63)
Finland 6.6 (6.4–6.8) 1.00 5.6 (5.0–6.3) 1.00
Norway 7.5 (7.3–7.7) 1.13 (1.10–1.17) 5.5 (4.9–6.1) 0.98 (0.87–1.09)
Sweden 6.7 (6.5–6.8) 1.01 (1.00–1.05) 5.3 (4.9–5.8) 0.95 (0.87–1.03)
≥1000 Canada 6.3 (6.2–6.4) 1.27 (1.26–1.30) 5.5 (5.2–5.8) 1.29 (1.21–1.36)
USA 7.6 (7.6–7.6) 1.55 (1.54–1.55) 7.2 (7.1–7.2) 1.68 (1.66–1.70)
Denmark 7.5 (7.3–7.7) 1.52 (1.48–1.56) 6.6 (6.0–7.3) 1.56 (1.42–1.71)
Finland 4.9 (4.8–5.1) 1.00 4.3 (3.7–4.8) 1.00
Norway 5.7 (5.5–5.8) 1.14 (1.11–1.18) 4.2 (3.7–4.8) 0.99 (0.87–1.13)
Sweden 5.8 (5.7–6.0) 1.19 (1.16–1.22) 4.6 (4.2–5.1) 1.09 (0.99–1.19)
All births Canada 11.1 (11.0–11.3) 1.51 (1.49–1.53) 11.5 (11.0–11.9) 1.84 (1.77–1.92)
USA 13.7 (13.6–13.7) 1.86 (1.85–1.86) 13.2 (13.1–13.3) 2.12 (2.10–2.13)
Denmark 9.0 (8.8–9.2) 1.22 (1.19–1.25) 9.1 (8.4–9.9) 1.46 (1.35–1.59)
Finland 7.4 (7.2–7.6) 1.00 6.2 (5.6–6.9) 1.00
Norway 12.7 (12.4–12.9) 1.72 (1.68–1.76) 10.6 (9.8–11.5) 1.71 (1.57–1.85)
Sweden 6.8 (6.7–7.0) 0.93 (0.90–0.95) 5.4 (5.0–5.9) 0.87 (0.80–0.95)
Rates are expressed per 1,000 total births. Numerator = Stillbirths + Infant deaths
aDenmark and Sweden did not report on stillbirths less than 28 weeks until 2004 and 2008, respectively
Only births with gestational age <22 weeks excluded from the rate calculation for births ≥22 weeks i.e., births with unknown gestational age included in
the calculations
Calculations of rates for births ≥28 weeks and birth weight ≥500 g and ≥1000 g were carried out in a similar manner
Finland was used as the reference category for calculation of rate ratios
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